A detailed history of Stance Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Stance Capital LLC holds 13,095 shares of AMGN stock, worth $3.78 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
13,095
Holding current value
$3.78 Million
% of portfolio
2.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Apr 14, 2025

BUY
$258.78 - $328.31 $3.39 Million - $4.3 Million
13,095 New
13,095 $3.41 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stance Capital LLC Portfolio

Follow Stance Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stance Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stance Capital LLC with notifications on news.